interaction records 54 assistance programs 55 0 personal data stored

Generic competition · all medicines · read 12 November 2026

Is there a generic of Sodium Chloride, and who makes it?

Sodium Chloride appears in 6 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 9 generic makers listed as marketed across them. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. Where both are dated, the first generic approval came between 2.2 and 42.3 years after the first brand approval. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Sodium Chloride6 dosage-form groups in the Orange Book
9generic makers listed
  1. Sodium Chloride appears in 6 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 9 generic makers listed as marketed across them.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Where both are dated, the first generic approval came between 2.2 and 42.3 years after the first brand approval.
  4. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Solution, Injection

Four or more generic makers listed

Brand listed as marketed: Bacteriostatic Sodium Chloride 0.9% In Plastic Container, Sodium Chloride 0.9% and Sodium Chloride 0.9% In Plastic Container. 6 generic makers with 16 generic products listed as marketed; the first generic approval is dated 10 January 1985.

1980198519901995200020052010201520202025203006brand 1982Fresenius Kabi Usa Llc, first approval 10 January 1985Taro Pharmaceuticals Usa Inc, first approval 11 August 2006Hikma Pharmaceuticals Usa Inc, first approval 24 September 2013Spectra Medical Devices Inc, first approval 21 July 2017Nephron Pharmaceuticals Corporation, first approval 23 April 2020Nexus Pharmaceuticals Llc, first approval 23 August 2023data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end
Generic maker (applicant)First approvalProducts
Fresenius Kabi Usa Llc10 January 19856
Taro Pharmaceuticals Usa Inc11 August 20062
Hikma Pharmaceuticals Usa Inc24 September 20132
Spectra Medical Devices Inc21 July 20172
Nephron Pharmaceuticals Corporation23 April 20202
Nexus Pharmaceuticals Llc23 August 20232

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Injectable, Injection

Four or more generic makers listed

Brand listed as marketed: Sodium Chloride 0.45% In Plastic Container, Sodium Chloride 0.9%, Sodium Chloride 0.9% In Plastic Container and Sodium Chloride 3% In Plastic Container. 4 generic makers with 8 generic products listed as marketed; the first generic approval is dated 27 October 2004.

1980198519901995200020052010201520202025203004brand 1983Gvs Tm Inc, first approval 27 October 2004Fresenius Medical Care North America, first approval 12 April 2007Laboratorios Grifols Sa, first approval 25 May 2017Fresenius Kabi Usa Llc, first approval 19 September 2017data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end
Generic maker (applicant)First approvalProducts
Gvs Tm Inc27 October 20041
Fresenius Medical Care North America12 April 20071
Laboratorios Grifols Sa25 May 20171
Fresenius Kabi Usa Llc19 September 20175

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Solution, Irrigation

One to three generic makers listed

Brand listed as marketed: Sodium Chloride 0.9% In Plastic Container. 1 generic maker with 1 generic product listed as marketed; the first generic approval is dated 24 June 2024.

1980198519901995200020052010201520202025203001brand 1982Fresenius Kabi Usa Llc, first approval 24 June 2024data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end
Generic maker (applicant)First approvalProducts
Fresenius Kabi Usa Llc24 June 20241

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Solution, Intravenous

One to three generic makers listed

Brand listed as marketed: Sodium Chloride 14.6% and Sodium Chloride 23.4%. 1 generic maker with 3 generic products listed as marketed; the first generic approval is dated 28 April 2021.

1980198519901995200020052010201520202025203001brand 1984Fresenius Kabi Usa Llc, first approval 28 April 2021data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end
Generic maker (applicant)First approvalProducts
Fresenius Kabi Usa Llc28 April 20213

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Aerosol, Metered, Inhalation

Nothing listed as marketed

Every brand product here is listed as discontinued. No generic is listed as marketed.

19901995200020052010201520202025203001brand 1992data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Solution For Slush, Irrigation

Brand listed, no generic listed as marketed

Brand listed as marketed: Sodium Chloride 0.9% In Sterile Plastic Container. No generic is listed as marketed.

198519901995200020052010201520202025203001brand 1985data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.